Breaking news

2027 A Pivotal Year for Cyprus’ First Natural Gas Exports, Says Energy Minister

Cyprus is set to reach a major milestone in 2027, as it prepares to transport its first natural gas, Minister of Energy, Commerce, and Industry George Papanastasiou said on Thursday.

Following a meeting with trade union SEK, Papanastasiou highlighted the significance of the upcoming agreement with Egypt, which President Nikos Christodoulides will personally underscore during his visit to the neighboring country.

“The signing of agreements that will commercialize Cyprus’ natural gas is a crucial step forward,” the minister stated. He noted that while discussions have long focused on exploration and reserves, the next and most critical phase—exporting gas to international markets—is now underway.

“These agreements will define how the gas reaches global markets. This process involves Egypt as the host country, the companies that have invested in the deposits, and, of course, the Republic of Cyprus, which is eager to bring its natural gas to the market,” he explained.

SEK Union Secretary General Andreas Matsas emphasized that the deal also holds strategic importance for the European Union in its push for energy independence.

Papanastasiou further stressed that revenues from natural gas and other investments will ultimately flow back into Cyprus’ economy, reinforcing the country’s financial stability and growth.

AI Expands Role In Consumer Healthcare And Drug Development

Artificial intelligence is increasingly used in consumer healthcare to manage personal data and support health-related decisions. Use cases range from administrative tasks, such as appointment scheduling and note-taking, to handling basic health queries. As these tools become more accessible, industry participants are encouraging broader use beyond routine functions.

AI As A Personal Health Advisor

The development of AI tools is extending into everyday health support. Alex Zhavoronkov, CEO of Insilico Medicine, said consumers can use AI systems to address routine health-related questions. Speaking at CNBC’s CONVERGE LIVE event in Singapore, he noted that some AI tools are capable of handling basic inquiries, allowing medical professionals to focus on more complex cases.

Major Tech Players Enter The Health Arena

At the same time, large technology companies are expanding into consumer health applications. OpenAI introduced ChatGPT Health, a platform that connects medical records and wellness applications to an AI interface. Similarly, Amazon launched HealthAI for users of One Medical, offering analysis of medical records, laboratory results, and current medications.

Balancing Innovation And Caution

As adoption increases, industry representatives are highlighting the need for oversight. Shreehas Tambe, CEO and Managing Director of Biocon, said that reliance on advanced systems without sufficient familiarity may introduce risks. He added that expert review remains necessary, particularly in areas such as drug development and clinical validation.

Revolutionizing Drug Discovery

Beyond consumer applications, AI is also reshaping pharmaceutical research. Development timelines for drug candidates can be reduced from more than four years to around 18 months. This shift is reflected in a $2.75 billion collaboration between Eli Lilly and Insilico Medicine, highlighting continued investment in AI-driven drug discovery.

Aretilaw firm
eCredo
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter